Private ADHD Assessment London 2026: Adult Diagnosis and Treatment Complete Guide
Medically reviewed by The Online GP by The Wellness clinical team | Last updated: April 2026
Private adult ADHD assessments in London 2026 cost £530 to £2,300 depending on the clinician and what is included, with most consultant psychiatrist-led assessments priced at £900 to £1,500. NHS waiting times for ADHD assessment in London now routinely exceed 3 to 5 years, with over 700,000 people on UK waitlists and only approximately 21,000 assessments completed in 2023 according to NHS England data. The disparity between need and NHS capacity has driven explosive growth in private ADHD assessment, where assessment within 2 to 6 weeks is standard. At The Online GP by The Wellness in Marylebone, comprehensive consultant psychiatrist-led adult ADHD assessment costs £895, with £195 titration consultations, £150 review appointments, and a £40 admin fee for repeat prescriptions between appointments. We work with your NHS GP to facilitate Shared Care Agreement transfer once your medication is stabilised, dramatically reducing long-term costs.
This guide explains exactly what adult ADHD is, what symptoms warrant assessment, how the NICE-compliant diagnostic process works, what medications are prescribed, how to navigate the NHS-versus-private decision, and why proper consultant psychiatrist assessment matters more than the cheapest online option.
Speak to a clinician today: WhatsApp +44 7961 280835 | Email team@thewellnesslondon.com | Call 020 3951 3429
What is adult ADHD?
Adult ADHD (Attention Deficit Hyperactivity Disorder) is a neurodevelopmental condition characterised by persistent patterns of inattention, hyperactivity, and impulsivity that significantly impair daily functioning across multiple settings. ADHD is not a disorder of attention deficit per se but rather a disorder of attention regulation: the difficulty is not lack of attention but inability to direct attention voluntarily to tasks the brain finds non-stimulating, while paradoxically being able to sustain intense focus (hyperfocus) on activities that engage the dopaminergic reward system.
ADHD is fundamentally biological, with strong genetic basis (heritability of approximately 70 to 80 percent) and identifiable structural and functional brain differences in dopamine and noradrenaline regulation, prefrontal cortex function, and default mode network activity. Brain imaging studies consistently show these differences, refuting older characterisations of ADHD as a behavioural choice or parenting failure.
ADHD presents in three main subtypes under DSM-5 criteria:
Predominantly Inattentive ADHD (formerly ADD) features primary difficulty with sustained attention, organisation, follow-through, and time management, without prominent hyperactive symptoms. This presentation is more commonly diagnosed in girls and women and is frequently missed in childhood, only being identified in adulthood when responsibilities exceed coping capacity.
Predominantly Hyperactive-Impulsive ADHD features prominent restlessness, impulsivity, and behavioural symptoms without the same level of attention difficulties. This is the classic "noticeable" presentation more commonly recognised in childhood, particularly in boys.
Combined Type ADHD features significant symptoms in both attention and hyperactivity-impulsivity domains. This is the most commonly diagnosed presentation in formal assessment.
In adults, hyperactivity often presents as internal restlessness rather than visible physical fidgeting: racing thoughts, inability to relax, constant mental activity, restless legs, and chronic foot-tapping or finger-drumming rather than the physical bouncing-off-walls behaviour seen in some children.
The scale of adult ADHD in the UK has been substantially under-recognised. NHS England estimates 2.5 million people in England have ADHD, with fewer than 1 in 5 adults with ADHD receiving an accurate diagnosis and appropriate treatment. The recent surge in adult ADHD diagnosis reflects growing awareness rather than any actual increase in prevalence, particularly amongst women, gifted individuals, and those whose intelligence allowed compensation through adolescence and early adulthood until life demands exceeded coping mechanisms.
What are the symptoms of adult ADHD?
Adult ADHD symptoms differ from the classic childhood presentation in important ways: hyperactivity often becomes internal rather than external, attention difficulties become more focused on executive function, and the impact on adult responsibilities (work, relationships, finances, parenting) becomes the predominant feature.
Inattention symptoms in adult ADHD:
Difficulty sustaining attention on tasks that lack inherent stimulation, particularly administrative tasks, paperwork, reading dense material, and routine work
Distractibility with frequent interruptions of train of thought by external stimuli or internal thoughts
Forgetfulness of appointments, deadlines, names, where you put things, and what you went to a room for
Disorganisation with persistent struggle to maintain organised systems despite repeated effort
Time blindness: inability to accurately perceive time passing, leading to chronic lateness, missing deadlines, or losing entire afternoons in a state of "frozen productivity"
Procrastination on important tasks, often replaced with secondary or unimportant activities
Difficulty starting tasks despite knowing they need to be done (executive dysfunction or "ADHD paralysis")
Difficulty completing tasks that have been started, with multiple unfinished projects
Working memory difficulties: forgetting what you were just told, struggling to follow multi-step instructions, losing your place in conversations
Frequent careless mistakes despite knowing the work
Avoidance of tasks requiring sustained mental effort
Hyperactivity symptoms in adult ADHD:
Internal restlessness more than physical hyperactivity
Difficulty relaxing without active engagement (films, social media, conversation, exercise)
Talking excessively or interrupting others
Foot tapping, leg bouncing, or finger drumming rather than gross motor restlessness
Mental hyperactivity: racing thoughts, inability to "switch off," difficulty falling asleep due to mental activity
Need for constant stimulation, leading to difficulty in low-stimulation environments
Impulsivity symptoms in adult ADHD:
Impulsive decisions with insufficient consideration of consequences, particularly around spending, relationships, career changes
Speaking before thinking, interrupting, blurting out comments
Difficulty waiting: in queues, in conversations, for delayed gratification
Risk-taking behaviours including driving, financial decisions, substance use
Emotional impulsivity with reactions out of proportion to triggers
Emotional and self-regulation symptoms (recently recognised as core ADHD features):
Rejection sensitivity dysphoria (RSD): extreme emotional response to perceived rejection or criticism
Emotional dysregulation: rapid mood shifts, difficulty managing emotions, low frustration tolerance
Hyperfocus: ability to sustain intense focus on engaging activities to the exclusion of basic needs (food, sleep, social commitments)
Sleep disturbance: difficulty falling asleep, restless sleep, difficulty waking
Chronic underachievement relative to apparent intellectual ability
Adult ADHD frequently coexists with other mental health conditions. Approximately 60 to 70 percent of adults with ADHD have at least one comorbid condition, most commonly anxiety disorders, depression, autism spectrum traits, sleep disorders, and substance use disorders. Identifying comorbid conditions is part of comprehensive ADHD assessment.
The diagnostic threshold is symptoms causing significant impairment across multiple settings (work, home, relationships) and present in childhood (typically before age 12, even if not formally diagnosed at that time). Brief attention difficulties or occasional disorganisation in otherwise high-functioning adults do not meet ADHD diagnostic criteria. The condition is defined by chronic, pervasive impairment.
Discuss your symptoms confidentially: WhatsApp +44 7961 280835
How is adult ADHD diagnosed?
Adult ADHD diagnosis follows NICE Clinical Guideline 87 and Royal College of Psychiatrists standards, requiring comprehensive assessment by a qualified specialist (typically a consultant psychiatrist with ADHD specialist training). The diagnostic process is thorough by design: ADHD shares symptoms with anxiety, depression, autism, sleep disorders, hormonal conditions, and trauma responses, and accurate differentiation requires structured assessment.
Stage 1: Pre-assessment screening. Validated self-report questionnaires including the Adult ADHD Self-Report Scale (ASRS), the Wender Utah Rating Scale (WURS) for childhood symptoms, and the DIVA-5 structured interview tool provide initial screening. A high score does not equal diagnosis but indicates assessment is appropriate.
Stage 2: Comprehensive psychiatric assessment. A 90 to 120 minute interview with a consultant psychiatrist covers:
Current symptoms across all 18 DSM-5 ADHD criteria, with specific examples and impact on daily functioning
Childhood history establishing symptom presence before age 12
School history including academic performance, behaviour, social functioning
Educational and work history including patterns of underachievement, job changes, difficulties with deadlines and authority
Relationship history including patterns in friendships, romantic relationships, family relationships
Mental health history screening for anxiety, depression, autism, OCD, eating disorders, substance use, mood disorders
Medical history including head injuries, sleep disorders, thyroid issues, hormonal conditions
Family history of ADHD, autism, mood disorders, learning differences (high heritability)
Substance and medication history including prescription medications and recreational substances
Differential diagnosis consideration of conditions that mimic or coexist with ADHD
Stage 3: Collateral information (helpful but not mandatory). Information from a parent, sibling, partner, or close friend who knew you well in childhood or knows you well now provides external corroboration of symptoms. School reports if available offer historical evidence. Many adults seeking ADHD assessment cannot access these documents and assessment proceeds without them where the clinical history is sufficient.
Stage 4: Diagnostic decision. Based on the assessment, the consultant psychiatrist confirms whether diagnostic criteria are met:
Sufficient symptoms in inattentive and/or hyperactive-impulsive domains
Symptoms present before age 12 (even if not formally diagnosed)
Impairment across multiple settings (work, home, social)
Symptoms not better explained by another condition
Specifier for predominantly inattentive, predominantly hyperactive-impulsive, or combined presentation
Stage 5: Comprehensive written report. A detailed report (typically 4 to 8 pages) documents:
Patient history and presentation
Validated questionnaire scores
Assessment findings
Diagnostic conclusion with DSM-5 specifiers
Differential diagnoses considered and ruled out
Treatment recommendations
Plan for medication titration if appropriate
Plan for shared care arrangement with NHS GP
Stage 6: Treatment discussion. If diagnosis is confirmed, the discussion of treatment options begins. This may happen in the same session if time allows or in a separate appointment. Options include medication, psychological therapies (CBT for ADHD, ADHD coaching), lifestyle interventions, and workplace accommodations.
At The Wellness, the assessment process is structured for thoroughness and efficiency:
Initial GP screening consultation (£150, 30 minutes): assessment of presenting concerns, validated screening questionnaires, and discussion of next steps
Comprehensive Adult ADHD Assessment (£895, 90 to 120 minutes): full consultant psychiatrist assessment with detailed written report
Treatment planning consultation (included in £895 assessment fee): discussion of medication and non-medication options, decision on next steps
The assessment itself can typically be booked within 1 to 3 weeks of initial enquiry. Comprehensive written reports are provided within 5 to 10 working days of assessment.
What medications treat adult ADHD?
UK adult ADHD medications fall into two categories: stimulants (methylphenidate-based and amphetamine-based) and non-stimulants (atomoxetine and guanfacine). NICE recommends stimulants as first-line treatment for most adults, with non-stimulants reserved for specific situations.
First-line stimulant medications:
Methylphenidate (brand names Ritalin, Concerta XL, Equasym XL, Medikinet XL, Delmosart XL). Methylphenidate works primarily by increasing synaptic dopamine and noradrenaline through reuptake inhibition. Available as immediate-release (4 to 6 hour duration) and various extended-release formulations (8 to 14 hour duration). Most adults use extended-release formulations once or twice daily. Typical adult doses range from 18mg to 90mg daily of Concerta XL or equivalent.
Lisdexamfetamine (brand name Elvanse, Vyvanse internationally). Lisdexamfetamine is a prodrug that converts to dexamphetamine in the body, providing 12 to 14 hour duration with smoother onset and offset than older amphetamine preparations. Increasingly used as first-line in adult ADHD due to longer duration and lower abuse potential. Typical adult doses range from 30mg to 70mg daily.
Dexamphetamine (brand name Amfexa). The active metabolite of lisdexamfetamine but in immediate-release form, providing 4 to 6 hour duration. Sometimes used as breakthrough dosing alongside extended-release lisdexamfetamine, or for patients who have not responded to other formulations. Typical adult doses 5mg to 60mg daily, divided.
Non-stimulant medications:
Atomoxetine (brand name Strattera). A noradrenaline reuptake inhibitor with delayed onset of effect (4 to 6 weeks for full effect) and 24-hour duration. Suitable for patients who cannot tolerate stimulants, those with substance use concerns, those with significant anxiety component, and those whose work or lifestyle does not suit stimulant timing. Typical adult doses 40mg to 100mg daily.
Guanfacine (brand name Intuniv). An alpha-2 adrenergic receptor agonist primarily used in childhood ADHD but increasingly in adults with prominent emotional dysregulation, sleep difficulties, or stimulant intolerance. Typical adult doses 1mg to 7mg daily.
Choice of medication depends on individual factors:
Cardiovascular history: Stimulants are cautious in significant cardiovascular disease but are generally safe with appropriate cardiac assessment
Mental health comorbidities: Severe anxiety may worsen with stimulants in some cases; bipolar disorder requires careful assessment before stimulant initiation
Substance use history: Lisdexamfetamine has lower abuse potential than dexamphetamine; atomoxetine has no abuse potential
Work demands: Stimulants suit demanding cognitive work; long-acting formulations cover full work day
Sleep patterns: Stimulants taken late in the day disrupt sleep; atomoxetine and guanfacine can be evening-dosed
Pregnancy and breastfeeding: Specific considerations require specialist input
Previous medication response: Prior trial responses inform current choice
Titration phase (typically 8 to 12 weeks):
After initial prescription, the medication is titrated to find the optimal dose: high enough for symptom benefit, low enough to avoid side effects. Typical pattern:
Week 1 to 2: Starting dose, monitoring for tolerability and initial response
Week 3 to 4: Dose increase based on response and side effects
Week 5 to 8: Further dose adjustments, often switching formulation or timing
Week 8 to 12: Optimal dose typically reached; regimen stabilised
During titration, review consultations every 2 to 4 weeks allow dose adjustment, side effect management, and refinement of timing. The Wellness charges £195 per titration consultation, with most patients requiring 3 to 4 consultations to reach stable dose.
Common side effects to monitor include reduced appetite, sleep difficulties, increased anxiety, headache, dry mouth, nausea, and modest cardiovascular effects (mild blood pressure and heart rate increase). Most side effects are dose-dependent and can be managed by dose adjustment. Serious side effects are uncommon but include cardiovascular events (very rare in well-screened patients), psychotic symptoms (very rare, typically reversible on discontinuation), and growth or weight effects in children (less relevant in adults).
Maintenance phase (after titration):
Once stable on optimal dose, 3 to 6 monthly review consultations assess ongoing effectiveness, side effects, and any need for adjustment. Many patients ultimately transition to NHS shared care with their GP prescribing under specialist guidance, dramatically reducing long-term costs.
Begin your ADHD treatment pathway: WhatsApp +44 7961 280835
What is Shared Care and how does it work?
Shared Care is a clinical and financial arrangement where your private specialist (consultant psychiatrist) provides ongoing diagnostic and treatment oversight, while your NHS GP takes over prescribing your stable ADHD medication on the NHS. This dramatically reduces long-term costs while maintaining specialist oversight.
How Shared Care works step-by-step:
Step 1: Private diagnosis and titration. You receive your ADHD diagnosis from a consultant psychiatrist privately and complete medication titration to a stable dose. This typically takes 3 to 6 months from initial assessment.
Step 2: Specialist proposes Shared Care Agreement. Once you are stable on medication, your consultant psychiatrist writes to your NHS GP proposing a Shared Care Agreement. This includes the diagnosis, treatment plan, current medication and dose, monitoring requirements, and the consultant's commitment to ongoing oversight.
Step 3: NHS GP considers the agreement. The GP reviews the proposal in line with local Integrated Care Board (ICB) policies. Some ICBs are supportive of ADHD shared care; others are more restrictive. Acceptance varies. The quality of the consultant's report substantially affects acceptance.
Step 4: GP issues NHS prescriptions. If accepted, the GP issues monthly NHS prescriptions for your stable ADHD medication. You pay only the standard NHS prescription charge (£9.90 per item in England in 2026, free in Scotland, Wales, Northern Ireland) rather than the full private medication cost.
Step 5: Specialist provides ongoing oversight. Your consultant psychiatrist sees you for periodic review (typically every 6 months to annually) to monitor treatment effectiveness, manage any complications, and adjust medication if needed. Between reviews, the GP manages routine prescribing.
Cost comparison: full private versus shared care:
Full private model:
Initial assessment: £895
Titration consultations (3 to 4): £585 to £780
Quarterly review consultations: £600 per year
Repeat prescription admin: £40 each (typically monthly)
Private medication cost: £100 to £250 per month
Annual cost after first year: approximately £2,500 to £3,500
Shared care model:
Initial assessment: £895 (one-time)
Titration consultations (3 to 4): £585 to £780 (one-time)
Annual specialist review: £150 to £250
NHS prescriptions: £119 per year (or free with exemption)
Annual cost after first year: approximately £270 to £370
The savings from shared care over a 5 to 10 year treatment period are substantial: tens of thousands of pounds. This is why facilitating shared care is a core part of how The Wellness manages ADHD long-term.
Factors affecting shared care acceptance:
Quality of diagnostic report: Consultant psychiatrist-authored reports following NICE standards have substantially higher acceptance rates
Local ICB policy: Some areas have explicit shared care frameworks; others leave decisions to individual GPs
Patient relationship with NHS GP: Established GP-patient relationships often facilitate acceptance
Stability on medication: Patients on stable doses for 3+ months have higher acceptance rates than those still in titration
Type of medication: Some GPs are more comfortable with certain medications than others
The Wellness approach to shared care: We write detailed NICE-compliant assessment reports specifically designed to support shared care transfer. We engage proactively with NHS GPs, providing clear information about ongoing monitoring requirements. We accept that some ICBs and GPs decline shared care, in which case we continue private prescribing with the patient.
How much does private ADHD assessment and treatment cost?
Private ADHD assessment in London 2026 ranges from £530 to £2,300 for initial assessment, with most consultant psychiatrist-led assessments at £900 to £1,500. Ongoing treatment costs vary based on titration duration, follow-up frequency, medication choice, and whether shared care is achieved.
Total first-year costs at The Wellness:
Initial GP consultation (£150) + Assessment (£895) + 3 titration consultations (£585) + 1 maintenance review (£150) = £1,780
Plus monthly medication costs paid at pharmacy
Total subsequent year costs at The Wellness with shared care:
1 to 2 specialist reviews (£150 to £300)
NHS prescriptions (£119 per year, or free with exemption)
Annual cost: approximately £270 to £420
Total subsequent year costs at The Wellness without shared care:
2 to 4 specialist reviews (£300 to £600)
12 repeat prescription fees (£480)
Private medication costs (£1,200 to £3,000)
Annual cost: approximately £2,000 to £4,000
The substantial gap between shared-care and private-only costs is why we work hard to facilitate shared care arrangements.
Insurance coverage is generally limited for ADHD assessment and treatment. Most UK private medical insurance policies treat ADHD as a chronic pre-existing neurodevelopmental condition and exclude assessment and treatment from standard cover. Some specialist mental health policies, certain corporate health benefits, and a small number of standard policies do cover ADHD. Always check your specific policy. Pre-authorisation is typically required.
Why choose The Wellness for ADHD assessment?
The Online GP by The Wellness offers a deliberately structured ADHD pathway combining consultant psychiatrist expertise with private GP integration and continuity. Six elements distinguish our approach.
Consultant psychiatrist-led diagnosis. ADHD assessment requires consultant psychiatrist expertise to provide diagnostic accuracy and prescribing authority. We work with consultant psychiatrists with specialist ADHD training and substantial NHS and private experience, ensuring NICE-compliant assessment and reports of the quality needed for shared care acceptance.
NICE-compliant assessment process. Our assessment follows NICE Clinical Guideline 87 and Royal College of Psychiatrists standards exactly. The 90 to 120 minute interview, validated questionnaires (DIVA-5, ASRS, Wender Utah), childhood history exploration, and differential diagnosis screening are all delivered systematically.
Same-week to 3-week appointment availability. From initial enquiry to comprehensive assessment is typically 1 to 3 weeks, dramatically faster than NHS pathways (1 to 5 years). Some appointments available within 7 days for urgent presentations.
Integrated GP service. Unlike standalone ADHD clinics, The Wellness is a full-service private GP practice. This means your ADHD care is integrated with your broader healthcare. Comorbid conditions can be assessed and managed in one place. Blood tests for medication monitoring, cardiovascular assessment, and physical health concerns are handled seamlessly.
Active shared care facilitation. We write reports specifically to support shared care transfer to NHS GPs. We engage proactively with NHS GPs about the proposal. Where shared care is accepted, we transition you smoothly. Where it is declined, we continue private prescribing with you.
Marylebone clinic with multilingual care. 10 Portman Square sits two minutes from Baker Street, adjacent to Harley Street. GMC-registered doctors fluent in English, Arabic, Spanish, French, and Dutch. International patients particularly value our integrated approach combining London-based assessment with ongoing remote review.
Continuity of care. You see the same consultant psychiatrist for assessment and ongoing reviews, building therapeutic relationship and clinical familiarity. WhatsApp access between appointments allows quick clarification of questions or concerns.
Begin your assessment pathway: WhatsApp +44 7961 280835
Frequently asked questions
Do I need a GP referral for a private ADHD assessment?
No. You can self-refer directly to The Wellness via WhatsApp, email, or phone. Many adults seeking ADHD assessment have not discussed concerns with their NHS GP and prefer self-referral for privacy or speed reasons. If you have a GP referral letter, sharing it is helpful but not required.
Will my employer find out about my ADHD diagnosis?
Not unless you choose to disclose it. ADHD diagnosis is confidential medical information held in your private medical records. You are under no legal obligation to disclose ADHD to employers. Many adults choose to disclose to access workplace adjustments under the Equality Act 2010, which can include flexible working, additional time for tasks, written instructions, or quieter workspace. Disclosure is your decision.
Can I drive while taking ADHD medication?
Generally yes. ADHD medication often improves driving by enhancing attention and reducing impulsive behaviours, and the DVLA does not restrict driving for adults on stable ADHD medication. The DVLA does require notification of certain medical conditions including narcolepsy, recurrent seizures, severe psychiatric conditions, and substance misuse. Stable adult ADHD on appropriate medication does not typically require notification, but check current DVLA guidance for your specific situation.
Can I have an ADHD assessment if I am already on antidepressants?
Yes. Many adults with ADHD have been treated with antidepressants for anxiety or depression that often coexist with ADHD or are misdiagnosed instead of ADHD. ADHD assessment can occur while you continue antidepressants. Your assessing psychiatrist will discuss whether to continue, modify, or eventually discontinue antidepressants based on your overall picture. Both conditions can coexist and require treatment.
What if my assessment shows I do not have ADHD?
Approximately 20 to 30 percent of patients seeking private ADHD assessment ultimately receive a different diagnosis or no diagnosis. The assessment process screens for autism, anxiety, depression, sleep disorders, hormonal issues, and trauma responses that can mimic ADHD symptoms. If you do not meet ADHD criteria, you receive a comprehensive understanding of what is causing your symptoms and recommendations for appropriate treatment, including referrals to relevant specialists.
Can I have ADHD and autism?
Yes. ADHD and autism are both neurodevelopmental conditions and frequently co-occur. Approximately 30 to 50 percent of people with autism also meet ADHD criteria, and a similar proportion of people with ADHD have autism traits. The combination is sometimes called "AuDHD." Assessment for one should consider the possibility of the other. We can arrange comprehensive neurodevelopmental assessment covering both ADHD and autism.
Can children get ADHD assessment at The Wellness?
The Wellness primarily provides adult assessment. For children and adolescents, we recommend specialist paediatric neurodevelopmental services with specific child psychiatrist involvement. We can provide referral pathways to suitable paediatric ADHD services. Adult patients with children also concerned about ADHD often benefit from family-based approach where parental ADHD assessment supports understanding of children's needs.
Book your ADHD assessment today
If you suspect you have ADHD and have been waiting on the NHS pathway, you do not need to keep waiting. The Online GP by The Wellness offers consultant psychiatrist-led adult ADHD assessment within 1 to 3 weeks, with NICE-compliant diagnostic process, comprehensive written report, structured medication titration, and shared care facilitation to transfer ongoing prescribing to your NHS GP for long-term cost savings.
Three ways to book today:
WhatsApp: Message +44 7961 280835 for a confidential same-day reply from our medical team.
Email: team@thewellnesslondon.com for detailed enquiries, complex history discussion, or international patient queries.
Phone: 020 3951 3429 to speak directly to our team during clinic hours.
The Wellness, 10 Portman Square, Marylebone, London W1H 6AZ. GMC-registered doctors. Same-week assessments. Consultant psychiatrist-led. £895 comprehensive assessment. NICE-compliant reports. Shared care facilitation.
References and further reading
NICE Clinical Guideline NG87 (Attention deficit hyperactivity disorder: diagnosis and management)
Royal College of Psychiatrists position on adult ADHD assessment and treatment
NHS England data on ADHD waiting times and assessment volumes
British Association for Psychopharmacology consensus guidelines on adult ADHD
DIVA-5 Adult ADHD Diagnostic Interview tool
Adult ADHD Self-Report Scale (ASRS) v1.1 by Kessler et al.
Wender Utah Rating Scale (WURS) for retrospective childhood ADHD symptoms
Barkley Executive Function Scale for adults
European Network Adult ADHD consensus statement on diagnosis and treatment
UKAAN (UK Adult ADHD Network) clinical practice guidelines
Disclaimer: This article is for educational purposes only and does not constitute medical advice. ADHD diagnosis requires comprehensive assessment by a qualified specialist. The Wellness is a private healthcare clinic working with consultant psychiatrists with specialist ADHD training. Assessments follow NICE Clinical Guideline 87 and Royal College of Psychiatrists standards.